申请人:——
公开号:US20030224421A1
公开(公告)日:2003-12-04
The invention concerns new oxazine derivatives of the general formula I
1
in which R
1
, R
4
, R
5
, R
6
, R
7
, R
10
denote hydrogen, alkyl, hydroxy, halogen, carboxyl, sulfonyl or amino and
R
2
, R
3
denote hydrogen, alkyl, alkoxy, polyoxyhydrocarbyl units, phenyl, phenylalkyl which can be substituted by hydroxy, sulfonyl, carboxy, amino, alkoxycarbonyl, in which R
2
with R
1
or R
3
with R
4
can form a saturated or unsaturated C2 or C3 bridge or R
2
with R
3
can form a saturated or unsaturated C4 or C5 bridge and
R
8
, R
9
denote hydrogen, alkyl, alkoxy, polyoxyhydrocarbyl units, phenyl, phenylalkyl which can be substituted by hydroxy, sulfonyl, carboxy, amino, alkoxy-carbonyl in which R
8
with R
7
or R
9
with R
10
can form a saturated or unsaturated C2 or C3 bridge or R
8
with R
9
can form a saturated or unsaturated C4 or C5 bridge
and in which at least one of the residues R
2
, R
3
, R
8
or R
9
represents a non-bridge forming residue which is additionally substituted by an activated group capable of coupling or by a group that can be activated to couple.
and in which at least one of the residues R
2
, R
3
, R
8
or R
9
represents a bridge-forming residue which can be optionally substituted by alkyl.
The derivatives serve to produce fluorescent conjugates for use in immunoassays and for DNA analysis.
本发明涉及一种新的氧杂环衍生物,其一般式为I1,其中R1、R4、R5、R6、R7、R10代表氢、烷基、羟基、卤素、羧基、磺酰基或氨基,R2、R3代表氢、烷基、烷氧基、聚氧烃基、苯基、苯基烷基,可以被羟基、磺酰基、羧基、氨基、烷氧羰基取代,其中R2与R1或R3与R4可以形成饱和或不饱和的C2或C3桥,或者R2与R3可以形成饱和或不饱和的C4或C5桥,R8、R9代表氢、烷基、烷氧基、聚氧烃基、苯基、苯基烷基,可以被羟基、磺酰基、羧基、氨基、烷氧羰基取代,其中R8与R7或R9与R10可以形成饱和或不饱和的C2或C3桥,或者R8与R9可以形成饱和或不饱和的C4或C5桥,至少有一个残基R2、R3、R8或R9代表一个非桥形成残基,其另外被活化的偶联基或可被活化的偶联基取代,至少有一个残基R2、R3、R8或R9代表一个可选地被烷基取代的桥形成残基。这些衍生物用于制备荧光共轭物,用于免疫分析和DNA分析。